the practice of incorporating modified or unmodified pieces of source code from existing software into the creation of new software
use of a program or abstract algorithm for an application different from the one for which it was originally written.
ImClone Systems Inc. and Genentech Inc. led shares of U.S. biotechnology companies higher after medicines they are developing helped cancer patients in studies .